---
title: "HK approves dorzagliatin by Hua Medicine for T2D management, first GKA approval outside China. Launchpad for international expansion."
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/277569713.md"
description: "A glucokinase-activator (GKA) has received its first approval outside mainland China, marking a significant milestone in the management of Type 2 diabetes (T2D). This approval signifies a unique approach to T2D treatment. Hong Kong has been chosen by Hua Medicine as the springboard for their expansion into the international market. The decision was made public in Shanghai and Hong Kong on March 3, 2026."
datetime: "2026-03-03T05:52:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/277569713.md)
  - [en](https://longbridge.com/en/news/277569713.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/277569713.md)
---

# HK approves dorzagliatin by Hua Medicine for T2D management, first GKA approval outside China. Launchpad for international expansion.

A glucokinase-activator (GKA) has received its first approval outside mainland China, marking a significant milestone in the management of Type 2 diabetes (T2D). This approval signifies a unique approach to T2D treatment. Hong Kong has been chosen by Hua Medicine as the springboard for their expansion into the international market. The decision was made public in Shanghai and Hong Kong on March 3, 2026.

### Related Stocks

- [02552.HK](https://longbridge.com/en/quote/02552.HK.md)
- [513700.CN](https://longbridge.com/en/quote/513700.CN.md)

## Related News & Research

- [Hua Medicine Announces 2025 Annual Results](https://longbridge.com/en/news/280735000.md)
- [HSA warns public against consuming herbal remedy containing potent steroid](https://longbridge.com/en/news/287022845.md)
- [10:30 ETInventHelp Inventor Develops New Line of Candies (SGM-681)](https://longbridge.com/en/news/286931125.md)
- [New York Governor Signs Bills To Preserve Mandatory Vaccines](https://longbridge.com/en/news/286947583.md)
- [09:35 ETOpen Medicine Launches Ahead of ASCO, Introducing "Living Algorithms" for Real-Time Oncology Decision-Making](https://longbridge.com/en/news/286923155.md)